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LETTERS TO THE EDITOR
Monitoring of the hypoglossal nerve during general
anesthesia
Injury to a cranial nerve during carotid surgery is a common
complication, with an incidence of more than 10%.1,2 In redo
procedures or in irradiated necks, the incidence is estimated to be
as frequent as 20%.3 The hypoglossal nerve is affected in more than
half of these patients.
Recently the use a nerve stimulator was described in the
Journal of Vascular Surgery.4 This nerve stimulator allowed iden-
tification and preservation of the hypoglossal nerve in a case of
carotid surgery in a scarred neck, but its use was restricted to an
awake, cooperating patient.
We recently used a commercially available neuromonitoring
system (NeuroSign 100; Inomed, Teiningen, Germany)—widely
used in thyroid surgery5—to monitor the hypoglossal nerve with
the patient under general anesthesia. A very thin detection needle
is placed in the ipsilateral half of the tongue; the earthening
electrode is placed in the sternocleidoid muscle. A stimulator is
then used to either identify the location of the nerve or to docu-
ment its function, which is proven through an acoustic and an optic
signal.
This easy method to identify the hypoglossal nerve and to
document its function may help to prevent the nerve’s injury in
locally complex situations. In contrast to the technique described
previously,4 it may also be performed with the patient under
general anesthesia.
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Regarding “Practical applications of hemodynamic
effect of intermittent pneumatic compression of the
leg after infrainguinal arterial bypass grafting”
This letter is in response to comments in the abstract section of
Journal of Vascular Surgery (2004;40:834) on our study originally
published in the British Journal of Surgery (2004;91:429-34).
Graft flow attenuation and surface thrombogenicity periop-
eratively, in a milieu of increased tissue thromboplastin release,
platelet reactivity, and coagulation factors, are known to enhance
significantly the likelihood of infrainguinal graft thrombosis.1 The
potential of assisting graft flow is appealing, particularly in patients
with run-off limitations and surgical imperfections amidst cardiac
or hematologic impairments; yet, there is a conspicuous scarcity of
such methods in practice.
By causing peripheral resistance to decrease, prostaglandins
generate a significant increase in graft flow. Iloprost, a synthetic
analogue of prostacyclin, offers a short-lived[20-min] flow enhance-
ment of 50% when infused into femorodistal grafts before perfu-
sion.1 In contrast, intermittent pneumatic compression (IPC)
enhances volume flow[median] in infrainguinal grafts by 76% when
applied to the foot (IPCfoot) and 236% when applied to the foot
and calf (IPCfootcalf).
1 Epidural anesthesia is also highly effective
in enhancing graft flow; however, its use is restrictive to patient’s
mobility and may prolong high dependency in-hospital care and
convalescence (Fig).
Optimal IPC function presupposes priming of the limb veins,
ensured by dependency.1 Yet, the theoretical potential of leg
edema did not prevent IPC becoming an indispensable tool for
preventing deep venous thromboembolism (DVT). Edema, or its
persistence, reflects an imbalance between fluid outflow through
the walls of the relatively high-pressure afferent limbs of the
capillary loops and osmotic reabsorption into the low-pressure
venous limbs. Courtesy of the venous emptying and pressure
attenuation in the lower limb, IPC reverses the effects of gravity,
preventing and or treating peripheral edema rather than causing it
to occur.2-5
Quoted from the abstract commentary “it is unclear whether
these devices will increase in postoperative discomfort in the oper-
ated extremity”. Yet, patients after arterial bypass grafting are given
regular analgesia. Furthermore, IPC implementation for DVT
prevention in orthopedic patients is well tolerated.2-5 Patients with
intra-articular fractures of the calcaneum treated with IPCfoot had
a significant improvement in movement, pain perception, and
convalescence, compared with controls.4 In critically ischemic
limbs, IPC is not only well tolerated but is also reported to offer
symptomatic relief due to the resulting arterial flow enhancement
(Table).6,7
Restricting “the practical significance of IPC” it is quoted that
the “pedal devices may be contraindicated in patients with pedal
gangrene and calf devices contraindicated in patients with distal
calf wounds.” Yet, different pneumatic cuffs and modes offer IPC
ample flexibility: IPCfootcalf may be used in femoropopliteal grafts
above the knee, IPCfoot in femorocrural grafts, IPC of the thigh in
popliteal-pedal grafts and IPCcalf with narrow cuffs in femoropop-
liteal grafts below the knee or femoropedal grafts.1 Long skin
bridges in saphenous procurement may further the applicability of
IPC, which may be used for intervals equal to those for DVT
prophylaxis.1
In our practice, amongst 100 patients offered infrainguinal
bypass grafting in the past 6 months, IPC implementation would
have been possible in 85% of patients. From this viewpoint the
data of the study abstracted and commented upon by Dr Moneta,
to whom I am grateful, warrant prospective evaluation to enable
determination of IPC’s actual efficacy, if any, in preventing throm-
bosis in grafts at risk perioperatively, or otherwise.
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